Posted on April 16th, 2014 by Bob Nellis
The road to developments that change medicine is jammed with great ideas. It meanders like a mountain trail in the early stages with many ideas failing and being discarded. But once an innovative medical breakthrough reaches the point of clinic research, the road runs straight as a Midwest highway through a patient-study unit nestled in Mayo Clinic’s campus in Rochester, Minn.
The Clinical Research Unit (CRU) is the unsung waypoint through which any number of landmark patient studies have traveled en route to improving the lives of millions of people, including revolutionary discoveries in osteoporosis, gastrointestinal distress, sleep apnea and cardiovascular disease, and diseases related to physiology. Here is a look at one [...]
Posted on April 7th, 2014 by Bob Nellis
We’re Drs. Winston Tan and John “Al” Copland and we collaborate in pursuit of cures for kidney cancer. Winston is a Mayo Clinic physician oncologist who treats kidney cancer patients and collaborates with Al, a Mayo scientist dedicated to kidney cancer research.
In talking with kidney cancer survivors and friends, we have been encouraged to begin a blog about our research efforts and discoveries in kidney cancer current FDA approved drugs are not cures. They provide some survival benefit (in a small [...]
Posted on April 3rd, 2014 by Nicole Brudos Ferrara
Mayo Clinic in Rochester, Minn., is seeking volunteers for a clinical trial for patients with human papillomavirus (HPV) positive tonsil or tongue (oropharynx) cancer whose disease has not spread outside of the neck. The purpose of the study is to find out if reducing treatment time and dosage can control the cancer while decreasing short-term and long-term side effects associated with treatment.
Who is eligible?
You may be eligible to participate in this study if you:
Posted on March 27th, 2014 by Gina Chiri-Osmond
Congratulations to Gregory Gores, M.D., who recently received the 2014 American Gastroenterological Association (AGA) Distinguished Mentor Award. Dr. Gores is the current Executive Dean for Research at Mayo Clinic in Rochester, Minn., responsible for the leadership and management of all Mayo research centers, divisions, programs, and other research activity. In assuming this role, Dr. Gores is recognized with the distinction of a named professorship: the Mr. and Mrs. Ronald F. Kinney Executive Dean for Research Honoring Ronald F. Kinney, Jr.
The American Gastroenterological Association is the trusted voice of the GI community. Founded in 1897, the AGA has grown to include more than 16,000 members from around the globe who are involved [...]
Posted on February 28th, 2014 by Bob Nellis
We want to pass on some published Mayo Clinic research as reflected in the media this week. This one, from the Annals of Thoracic Surgery is especially interesting and useful to both physicians and patients alike.
HealthDay, Getting Teeth Pulled Before Heart Surgery May Pose Serious Risks by Randy Dotinga…In a small, retrospective study, Mayo Clinic researchers found that 8 percent of heart patients who did not wait to have teeth pulled suffered major adverse health outcomes, such as a heart attack, stroke, kidney failure or death. "Guidelines from the American College of Cardiology and American Heart Association label dental extraction as a minor procedure, with the risk of death or non-fatal heart attack estimated to be less than 1 percent," study co-author Dr. Mark Smith [...]
Posted on January 2nd, 2014 by Admin
A Mayo Clinic researcher, along with collaborators from Harvard Medical School, developed a method to first identify a breast-cancer-promoting gene and then specifically target this gene with a nanoparticle-based, injectable therapy that reverses breast cancer in mice. The results, published this week in Science Translational Medicine, may provide a first step in developing a new non-surgical treatment option for patients diagnosed with early-stage breast cancer.
Posted on December 18th, 2013 by Admin
From Mayo Clinic's Discovery's Edge magazine
Many prostate cancer survivors live in fear of being told that their cancer has returned. It’s even scarier to be told that the doctor knows the cancer is there because of rising PSA levels, but that he can’t find it. Doctors and patients alike know that early detection of the recurrent cancer is critical to the patient’s chance of beating it a second time.
The problem, however, is locating it.
A Mayo Clinic research team has developed a new imaging technique that can often find the recurrent disease months, if not years, earlier than other imaging techniques. Prostate cancer uses choline, a B-complex vitamin, as [...]
Posted on December 16th, 2013 by Jason Pratt